{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:57:40Z","timestamp":1781272660084,"version":"3.54.1"},"reference-count":8,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"DOI":"10.1111\/jdv.70573","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:06:24Z","timestamp":1781269584000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["<scp>HiSCR<\/scp>\n                    is not\n                    <scp>PASI<\/scp>\n                    : Misleading primary outcomes in hidradenitis suppurativa clinical trials"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2874-7726","authenticated-orcid":false,"given":"H. H.","family":"van der Zee","sequence":"first","affiliation":[{"name":"Department of Dermatology Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-3814","authenticated-orcid":false,"given":"K. R.","family":"van Straalen","sequence":"additional","affiliation":[{"name":"Department of Dermatology Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-3674","authenticated-orcid":false,"given":"B.","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Medical Center Groningen, University of Groningen  The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"5","key":"e_1_2_2_2_1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball AB","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"e_1_2_2_3_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (hidradenitis suppurativa clinical response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo\u2010controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball AB","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10443","key":"e_1_2_2_4_1","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate\u2010to\u2010severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48\u2010week, randomised, double\u2010blind, placebo\u2010controlled multicentre phase 3 trials","volume":"403","author":"Kimball AB","year":"2024","journal-title":"Lancet"},{"key":"e_1_2_2_5_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.33590\/emjdermatol\/10300534","article-title":"Secukinumab for patients with moderate\u2010to\u2010severe hidradenitis suppurativa: post hoc analyses of efficacy endpoints, draining tunnels, skin pain, and work productivity","volume":"11","author":"Duffy J","year":"2023","journal-title":"EMJ Dermatol"},{"key":"e_1_2_2_6_1","article-title":"Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: results from BE HEARD I and II","author":"Zouboulis CC","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_2_7_1","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.70356","article-title":"Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: results from BE HEARD I and II","author":"Tzellos T","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"e_1_2_2_8_1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jdv.20369","article-title":"Secukinumab efficacy in patients with hidradenitis suppurativa assessed by the International Hidradenitis Suppurativa Severity Score System (IHS4): a post hoc analysis of the SUNSHINE and SUNRISE trials","volume":"39","author":"Zouboulis CC","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"e_1_2_2_9_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jdv.18632","article-title":"Development and validation of IHS4\u201055, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa","volume":"37","author":"Tzellos T","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70573","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.70573","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:06:26Z","timestamp":1781269586000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.70573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":8,"alternative-id":["10.1111\/jdv.70573"],"URL":"https:\/\/doi.org\/10.1111\/jdv.70573","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"2026-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jdv.70573"}}